Nalbuphine Hydrochloride Injection is supplied as a sterile solution in single-dose ampuls and multiple‑dose fliptop vials for intramuscular, subcutaneous, or intravenous administration, and available as follows:
| Unit of Sale | Concentration |
|---|---|
NDC 0409-1463-01 | 10 mg/mL |
Tray of 10 – 1 mL Single-dose Ampuls | |
NDC 0409-1465-01 | 20 mg/mL |
Tray of 10 – 1 mL Single-dose Ampuls | |
NDC 0409-1464-01 | 100 mg/10 mL |
Case of 25 – 10 mL Multiple-dose Fliptop Vials | (10 mg/mL) |
NDC 0409-1467-01 | 200 mg/10 mL |
Case of 25 – 10 mL Multiple-dose Fliptop Vials | (20 mg/mL) |
{{section_name_patient}}
{{section_body_html_patient}}
Additional Resources
Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine or vaccine.
Speak with a Pfizer Medical Information Professional regarding your Pfizer medicine or vaccine inquiry.
Available 9AM-5PM ET Monday to Friday; excluding holidays.
Submit a medical question for a Pfizer medicine or a vaccine.
The submission will be reviewed during our standard business hours.
To report an adverse event related to a Pfizer product and you are not part of a clinical trial* for this medication, click the link below to submit your information:
Pfizer Safety Reporting Site
*If you are involved in a clinical trial for either product, adverse events should be reported to your coordinating study site.
If you cannot use the above website to report an adverse event related to a Pfizer medication, please call (800) 438-1985.
You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatch or by calling (800) 332-1088.